A shockwave reverberated through the Alzheimer's research community today after pharmaceutical company Biogen announced it was discontinuing two massive final phase human trials into the previously promising Alzheimer's drug aducanumab. The announcement is the latest in a long line of failed Alzheimer's drugs targeting the popular amyloid protein hypothesis.
.. Continue Reading Another big Alzheimer’s drug fails in late-stage human trialsCategory: Medical
Tags:
from New Atlas (Gizmag) https://ift.tt/2FiTwqG
No comments:
Post a Comment